Biopsy to collect limbal epithelial stem cells that will be cultivated into a graft + CALEC Transplant + Cultivation of Limbal epithelial cells into a graft for corneal neovascularization

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Oct 2015: Trial registered, NCT02592330
  2. 1 Aug 2016: Trial started, NCT02592330

The trials

NCT02592330: Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft

State
Completed
Phase
Phase 1 and Phase 2
People
23 taking part
Started
1 Aug 2016
Primary completion
31 Mar 2023
Arms
Cultivated Autologous Limbal Epithelial Cell (CALEC) graft
Results
Posted on the registry
  1. 30 Oct 2015: Trial registered
  2. 1 Aug 2016: Trial started
  3. 31 Mar 2023: Trial completed
  4. 15 Jan 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.